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Abstract
Separating cardioembolic from large artery stroke has important treatment implications. We investigated whether
echocardiography could improve Cardioembolic Stroke (CES) prediction compared with traditional measures and cholesterol
biomarkers.
Data from 40 consecutive patients presenting with acute ischemic stroke which included brain and carotid imaging, ECG,
echo, serum cholesterol and apolipoproteins were independently reviewed. Patients were classified into two groups: a) CES,
defined by sustained or paroxysmal atrial fibrillation and <50% stenosis of a perfusing cerebral artery; b) Large artery stroke
(LAS) defined as > 50% stenosis of an ipsilateral perfusing cerebral artery, with no evidence of AF on monitoring or evidence of
small artery disease on neuroimaging and confirmed by an independent neurologist.
Other than the CES group being older, the baseline characteristics of the two groups were similar. Left Atrial Volume
(indexed for body surface area, LAVi) was significantly larger in CES (57.9 +/- 19.4 vs 31.1 +/- 8.3ml/m2, p<0.01), with a simple
equation that utilised age, LAVi and E wave accurately predicting 90% of CES. The difference in LAVi for CES was beyond that
anticipated from the presence of AF alone. No differences in any of the lipid biomarkers were observed.
These finding indicate that LAVi is the most important predictor of CES due to atrial fibrillation and is highly predictive of
patients with CES due to atrial fibrillation. Cholesterol biomarkers offered no additional discriminatory value.
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[6], atrial fibrillation is considered the most likely primary risk
factor [4].

Introduction
As stroke is a heterogeneous disease there is a pressing
need for accurate and early determination of stroke subtype [1]
as this can have significant impact on patient management [2] and
outcomes [3].

While echocardiography has been recommended to help
determine the cardioembolic source of stroke and to inform primary
and secondary prevention strategies of a secondary stroke [6], the
diagnosis of Cardioembolic Stroke (CES) is often inferential;
based on supportive historical data, neuroimaging, and less often,
the identification of a cardiac source for the patient [7].

Cardioembolic cerebral infarction accounts for 30% [4]
of all cerebral infarcts and often result in poor patient outcomes
including increased risk of recurrence and early mortality [5].
Although the emboli may originate from multiple cardiac sources

Earlier studies have demonstrated an association between
left atrial size and ischaemic stroke [8], even in patients without
atrial fibrillation [9]. More recent studies have extended this
observation to cardioembolic and other stroke sub-types [10-12].

1

Volume 2018; Issue 01

Citation: Playford DA, Bowler S, Bulsara M, Blacker DJ, Bates TR, et al. (2018) The Importance of Left Atrial Volume Assessment in Identifying the Cause of Ischemic
Stroke. Ar Clin Cardiol Res: ACCR-103. DOI: 10.29011/ACCR-103/100003

To date however, no studies have investigated degree of left atrial
enlargement as a predictor of cardioembolic stroke in patients with
atrial fibrillation, and the potential of using left atrial volume to
differentiate CES from other forms of stroke.

and less than 50% stenosis in an artery supplying the region of
stroke, or b) LAS defined by atherosclerosis of an artery supplying
the region of stroke, with no evidence of AF or small artery disease
on neuroimaging.

The purpose of this study is to determine whether
echocardiographic parameters can be used to differentiate CES
from those due to atherosclerotic emboli of a large artery.

The data were analysed using SPSS statistics version 22.
Categorical variables were summarized as percentages while
continuous variables were expressed as means and standard
deviations. Differences were determined using the Chi-square
statistic and Fishers Exact Test for categorical variables or t-test for
continuous variables. The contribution of various atrial measures
against LAVi was determined by ANOVA with comparison of
F scores and their probabilities. Associations between stroke
type and other variables were assessed using multiple logistic
regression modelling. Receiver operating characteristics curves
were constructed to assess discrimination between CES and LAS
using STATA version 13.

Methods
Adult patients presenting to a district hospital in Perth,
Western Australia with an acute ischaemic stroke within 48 hours
of symptom onset were identified using full clinical history,
neurological examination and laboratory analyses, lipid profile
including apolipoproteins (ApoA1, ApoB, and Lp (a)), and an
Electrocardiogram (ECG). Baseline Brain Computed Tomography
(CT) was performed for each patient. 24-48 hour ambulatory ECG
monitoring (Holter monitor) was performed if Atrial Fibrillation
(AF) was not present on a resting Electrocardiogram (ECG).
Cervical artery imaging (carotid ultrasound, CT angiography or
time of flight MR Angiography) was performed for all patients.
Follow-up neuroimaging (brain CT or MRI) was performed as
clinically indicated.
Brain CT, MRI and cervical artery imaging were reviewed
by an independent neurologist (DJB) and patients were classified
as Large Artery Stroke (LAS) or presumed CES. Patients who
potentially had other forms of stroke where excluded from this
study. The neurologist was blinded to the presence or absence of
atrial fibrillation, the echo findings and the laboratory analyses.
Full transthoracic echo (TTE) was performed in all patients
in a single laboratory using standard criteria [13]. Left Atrial
Volume (LAV) was assessed using the recommended criteria [14],
and indexed for body surface area (LAVi). Mitral inflow E wave
velocity, E:E’, left ventricular mass index and pulmonary artery
systolic pressure were all calculated using published criteria [15].
In the setting of atrial fibrillation, the mitral A wave was absent,
and E wave and E’ velocities were only measured if felt clinically
appropriate.
Patients were classified into one of two groups: a) CES,
defined by the presence of sustained or paroxysmal atrial fibrillation

2

This project followed the ethical guidelines set out by the
National Health and Medical Research Council of Australia, and
received approval from by the Human Research Ethics Committees
(HREC) of Sir Charles Gairdner Hospital and The University of
Notre Dame of Australia.

Results
40 patients with definite ischaemic strokes were included;
20 with LAS and 20 with CES. Clinical classification, performed
at the time of the stroke, was completely concordant with the
independent neurologist review.
For the entire group, the mean age was 70 ±13.5 years 25
(63%) were male, 22 (55%) were current or previous smokers, 30
(75%) had hypertension and 12 (30%) had diabetes mellitus. The
baseline clinical characteristics of the two groups were similar
except for the CES group being older (77 vs 64 years, p<0.001)
and more likely to be on antihypertensive medication (95% vs
65%, p<0.001) than patients in the LAS group (Table 1). The most
commonly prescribed antihypertensive medication was a reninangiotensin blocking agent. All patients with CES were noted to
have atrial fibrillation during their hospital admission, whereas no
patients with LAS had atrial fibrillation during their admission or
on subsequent continuous ECG monitoring.

Volume 2018; Issue 01

Citation: Playford DA, Bowler S, Bulsara M, Blacker DJ, Bates TR, et al. (2018) The Importance of Left Atrial Volume Assessment in Identifying the Cause of Ischemic
Stroke. Ar Clin Cardiol Res: ACCR-103. DOI: 10.29011/ACCR-103/100003

Variable

LAS

CES

p-value

Age in years, mean (SD)+/- SD)

63.7 (13.4)

77.4 (7.1)

<0.001*

Male, n (%)

14 (70%)

11 (55%)

0.51

SBP at stroke, mean (SD)

152 (15)

152 (21)

0.93

Diabetes mellitus

6 (30%)

6 (30%)

1.00

Hypertension

16 (80%)

14 (70%)

0.72

Prior IHD diagnosis

6 (30%)

11 (55%)

0.20

GFR < 60ml/min

4 (20%)

8 (40%)

0.30

Smoking status

9 (45%)

2 (10%)

0.06

Alcohol Consumption

11 (55%)

8 (40%)

0.19

Antiplatelets

10 (50%)

16 (80%)

0.10

Anticoagulants

2 (10%)

1 (5%)

1.00

Statin therapy

8 (40%)

9 (45%)

1.00

Antihypertensive therapy

13 (65%)

19 (95%)

0.04*

Total cholesterol

3.95 (1.17)

3.70 (1.08)

0.50

LDL

2.47 (0.82)

2.36 (0.95)

0.68

HDL

1.07 (0.29)

1.16 (0.42)

0.46

Triglycerides

1.96 (1.57)

1.33 (0.61)

0.10

APO A1

1.20 (0.25)

1.21 (0.28)

0.98

APO B100

0.81 (0.29)

0.76 (0.26)

0.54

Lp (a)

0.33 (0.38)

0.38 (0.43)

0.66

Comorbidities, n (%)

Risk behaviours, n (%)

Medications prior to stroke, n (%)

Lipid biomarkers, mean (SD)

Data are presented as mean (SD) or as the number, n (%). P-values were calculated using independent samples t-test or Fishers Exact Test for
continuous and categorical variables respectively. SBP: Systolic Blood Pressure; GFR: Glomerular Filtration Rate; IHD: Ischaemic Heart Disease;
LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein, APO A1: Apolipoprotein A1; APO B100: Apolipoprotein B100; Lp (a):
Lipoprotein (a). * P<0.05 for difference between groups by t-test or Fishers Exact test as appropriate.
Table 1: Clinical characteristics: Large Artery Stroke (LAS) vs Cardioembolic (CES).
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Lipid and Lipoprotein Profiles
No significant difference in any of the measured lipids,
lipoproteins or apolipoproteins was identified between the two
groups (Table 1).

Echocardiography
The indexed LAV (LAVi) was significantly larger in those
with CES compared with LAS (CES 57.9 ± 19.4 ml/m2 v LAS 31.0
± 8.3 ml/m2, p<0.001, Figure 1).

septal E’ velocity not being significantly different. E:A ratio could
not be compared because of the absence of a mitral inflow A wave
velocity in atrial fibrillation. The estimated Pulmonary Artery
Systolic Pressure (PASP) was numerically but not statistically
different, measuring 42.8 ± 13.4 mmHg in the cardioembolic group
and 32.5 ± 2.12 mmHg in the large artery group. Accurate data on
PASP was only available in 14 patients (41%) due to insufficient
tricuspid regurgitation in the remainder.
Mitral valve disease was more common in patients with CES
with 50% of patients having mild or moderate mitral regurgitation
compared with only a single patient in the LAS group (p<0.001).
No patients had severe mitral regurgitation. Despite trends toward
more significant aortic valve disease in the cardioembolic group,
these were not significant (Table 2).
Parameter

LAS

CES

p-value

31.1 (8.3)

57.9 (19.4)

<0.001*

LV mass index (g/m2)

87.4 (29.6)

118.3 (40.2)

0.02*

LV diastolic diameter
(cm)

4.69 (0.68)

4.72 (0.95)

0.02*

Ejection Fraction (%)

63.7 (9.7)

57.4 (17.1)

0.92

E wave (cm/s)

71.6 (20.0)

103.5 (28.6)

0.001*

E’ velocity (cm/s)

7.2 (2.2)

6.1 (2.0)

0.23

E:E’

10.6 (2.9)

18.8 (8.4)

0.006*

PASP (mmHg)

32.5 (2.12)

42.8 (13.4)

0.31

Mild or moderate MR,
n (%)

1 (5%)

10 (50%)

0.001*

Mild MS, n (%)

0 (0%)

1 (5%)

0.49

Mild AR, n (%)

0 (0%)

3 (17%)

0.23

Mild AS, n (%)

7 (35%)

2 (10%)

0.12

Severe AS, n (%)

0 (0%)

3 (15%)

0.23

TTE measure, mean
(SD)
LA volume index (ml/
m2)

Figure 1: Box plots of LAVi by stroke type. The line inside each box
represents the median, the upper and lower limits of the boxes represent
the 25th and 75th percentiles respectively with the bars representing the
10% and 90% range. Points outside this range are shown as ‘o’ and ‘*’.

The ejection fraction was similar between groups (64 ± 10%
vs 57 ± 17%, p=0.3). To identify the cause for left atrial enlargement,
LV mass, diastolic function and valvular abnormalities were
evaluated. Left ventricular mass was significantly higher in those
with CES compared with their large artery counterparts (118 ± 40
g/m2 vs 87 ± 30 g/m2, p=0.02).
There were significant differences in diastolic function
between the two groups. Mitral inflow E waves were higher in
CES (104 ± 29 ml/m2 vs 72 ± 20 ml/m2, p<0.001), and the medial
mitral annular descent velocities (E’) were numerically but not
significantly lower (6.1 ± 2.0 cm/s vs 7.2 ± 2.2 cm/s, p=0.2), which
may be due to the low numbers of E’ measurements performed in
the setting of atrial fibrillation (27 E’ measurements performed).
The ratio of E:E’ as a marker of LV filling pressures, was higher
in the CES group (18.8 ± 8.3 vs 10.6 ± 2.9, p=0.004). Measures of
diastolic function associated with LAVi were left ventricular mass
(F=3.27, p=0.04) and E:E’ ratio (F=3.6, p=0.03), with E wave and
4

Valvular disease

LV: Left Ventricle; LA: Left Atrium; PASP: Estimated Pulmonary
Artery Systolic Pressure. For valvular disease, MR: Mitral
Regurgitation; MS: Mitral Stenosis; AR: Aortic Regurgitation; AS:
Aortic Stenosis. No patients in our cohort had greater than moderate
MR or MS, and no patients had moderate or greater AR. No LAS
patients had moderate AS. *P<0.05 for difference between groups by
t-test or Fishers Exact test as appropriate.
Table 2: Echocardiography parameters: Large Artery Stroke (LAS) vs
Cardioembolic Stroke (CES).
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Predicting Cause of Stroke
Logistic regression was used to determine the contribution of several variables in predicting stroke type. Various models were
constructed using the available cardiac parameters produced by TTE. The model developed using both LAVi (p=0.05) and E wave
(p=0.55) resulted in the greatest Pseudo R2 and area under the ROC curve (AUC) estimates (65.7% and 96.1% respectively). Age at
stroke was kept in the model (p=0.16) as it was considered an important clinical determinant and had minimal impact on the model’s R2
and AUC values (Table 3). Model 2, utilising only age and LAVi, was also significant (p=0.015) but with lower with Pseudo R2 (56.4%)
and ROC area under the curve values (93.8%, Table 4, Figure 2). Similar modelling based on E wave was not significant.
Variable

Coefficient

SE

p-value

Odds ratio (95% CI)

0.1576

0.1111

0.156

1.17 (0.94–1.46)

LA volume index (ml/m )

0.1313

0.0671

0.050*

1.14 (1.00–1.30)

E wave (cm/s)

0.0645

0.0336

0.055

1.07 (1.00–1.14)

Age at stroke (years)

0.1095

0.0641

0.088

1.12 (0.98–1.27)

LA volume index (ml/m2)

0.1237

0.0508

0.015*

1.13 (1.02–1.25)

Model 1 (n=30)
Age at stroke (years)
2

Model 2 (n=34)

Logistic regression model based on 30 observations with for predicting stroke type. Pseudo R and ROC area under the curve were 65.7% and
96.1% for Model 1; and 56.4% and 93.8% for Model 2. *P<0.05.
2

Table 3: Multiple logistic regression model for the prediction of cardioembolic stroke.
Model

AUC

Optimal Cut-off

Sensitivity

Specificity

Correctly classified

Model 1 (n=30)

0.961 (0.900-1.021)

0.57

86.7%

93.3%

90.0%

Model 2 (n=34)

0.938 (0.866-1.00)

0.68

75.0%

94.4%

85.3%

Model 1 is a predictive model based on age, LAVi and E wave measurements while Model 2 is based only on age and LAVi. AUC = ROC area
under the curve.
Table 4: Diagnostic properties of predictive models.
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driver for increased LAV appearing to be abnormal diastolic
function with increased filling pressures. Mitral E wave velocity, a
measure of early diastolic filling, was higher in the cardioembolic
group, as was the E:E’, a marker of left ventricular filling. In atrial
fibrillation, the E wave velocity may increase in the absence of an
A wave. However, multivariate analysis revealed a 14% increase
in CES risk for every unit increase in LAVi even after controlling
for age and E Wave velocity.

Figure 2: ROC plot of sensitivity and specificity for the stroke prediction
model. Receiver operating characteristic (ROC) curves for Model 1 and
2 discriminations of CES from LAS. Dots represent points from Model
1. Statistical comparison of the AUC of both models by Chi2 shows no
significant differences (p=0.327).

The equation from the modelling that yielded the best predictor of
CES was:
Model 1: (86.7% sensitivity and 93% specificity at probability
cut-off 0.57): CardioEm = exp(-22.6454 + 0.1576 * Age + 0.1313
* LAVi + 0.0645 * Ewave) Probability, p(CardioEM) = (CardioEm
/ (1 + CardioEm) If p(CardioEm >= 0.50 then the patient is likely
to have had CES

Discussion
This study demonstrated that, in patients with atrial fibrillation
on presentation with ischaemic stroke, LAVi was the single most
important predictor of CES with abnormal diastolic function
appearing to be the primary driver of left atrial enlargement. Age
was not a significant risk factor for stroke after correction for
LAVi. No lipid biomarker, alone or in combination, was useful to
separate CES from LAS, and therefore cannot be recommended as
a diagnostic tool. Similarly, presentation blood pressure was not
useful as a discriminator. The clinical classification of patients into
CES and LAS was confirmed via independent neurological review,
blinded to the echo and ECG findings, further strengthening our
result.

Left Atrial Volume and Stroke
LAVi was significantly higher in the CES group, with the
6

LAV is considered a marker of chronically increased left
atrial pressure [16], and a large left atrium is associated with atrial
fibrillation [17,18]. Possible causes for left atrial enlargement
include valvular disease and diastolic dysfunction [19]. Left
ventricular systolic dysfunction has also been associated with
ischemic stroke [20]. The CES group had a higher LV mass than
those in the LAS group (Table 2) despite similar blood pressures
on presentation. A greater proportion of patients in the CES group
were receiving antihypertensive therapy than those in the LAS
group, consistent with hypertension being more prevalent in the
CES group. We found a higher E:E’ ratio in the CES group but
similar E’ velocities (Table 2), suggesting that that the E wave
velocity was the predominant driver for the higher E:E’ ratio in the
CES group. It is possible the increased E wave velocity was due
to atrial fibrillation itself (and the absence of an atrial contraction
wave) rather than diastolic dysfunction, but the increased left atrial
volume, increased left ventricular mass and higher pulmonary
artery pressures suggest possible diastolic dysfunction. In the
setting of left ventricular hypertrophy and diastolic dysfunction,
atrial fibrillation is likely to have developed as a result of these
primary abnormalities.
Atrial fibrillation is known to induce left atrial remodelling
and atrial enlargement [21], particularly with chronic atrial
fibrillation. However, the difference in left atrial volume in our two
groups was large (26.8 ml/m2) and beyond that described where
the arrhythmia appears to be the only driver [22]. There appear to
be other additional drivers of increased left atrial volume at play,
such as abnormal diastolic filling parameters as described above.
Mitral regurgitation, which can cause left atrial enlargement
and atrial fibrillation, is commonly found in patients with CES
[23]. We found that half of the patients with CES had mild or
moderate mitral regurgitation, compared with only 1 patient in the
LAS group. We did not explore this possible association further
because of small numbers.
Another study found LAV was an independent predictor of first
ischemic stroke in patients without documented atrial fibrillation
[24]. The Framingham heart study found that an enlarged LAV was
associated with increased stroke incidence even when adjusted for
age, hypertension, left ventricular hypertrophy and prevalent atrial
fibrillation. However, neither of these studies examined LAVs in
differing causes of stroke. The paroxysmal nature of some atrial
Volume 2018; Issue 01

Citation: Playford DA, Bowler S, Bulsara M, Blacker DJ, Bates TR, et al. (2018) The Importance of Left Atrial Volume Assessment in Identifying the Cause of Ischemic
Stroke. Ar Clin Cardiol Res: ACCR-103. DOI: 10.29011/ACCR-103/100003

fibrillation makes it difficult for echo follow-up studies to rule
out the disease, particularly if it develops after the initial echo
study was performed. We note another study examined whether
echocardiography can predict Paroxysmal Atrial Fibrillation (PAF)
as diagnosed by 7-day Holter monitoring, in patients with cerebral
ischemia presenting in sinus rhythm. These authors concluded that
the ratio of indexed LAV to an E:A wave ratio <2.3 can effectively
rule out paroxysmal atrial fibrillation [25]. We did not examine
this association, since patients in the CES group in our study had
confirmed persistent AF and no A-wave was present on echo.
However, other studies have recently reported changes in
LAVi by stroke sub-types, with patients with CES being significantly
higher than other forms of ischaemic stroke [11,12,26]. While
differences in patient classification and study design make direct
comparison between these and our own study difficult, collectively
they demonstrate the value of using LAVi to identify CES patients
as part of the clinical decision to utilise anticoagulants. While, like
Shaikh et al. we noted the risk of CES increased with a LAVi ≥
34 ml/m2, our study also demonstrated improved discrimination
between LAS and CES patients could be achieved by also
utilising the patient’s E wave measurements. Introduction of other
electrocardiographic measures into the model failed to improve
the discernment of the stroke types but this needs to be further
investigated in a larger sample of patients.

Age and Stroke
Age, which is a known predictor of atrial fibrillation, was
significantly greater in the CES group, a finding that is consistent
with previous studies [27,28]. However, we found that age no
longer remained a significant predictor of CES when corrected for
atrial volume, a finding consistent with the work of Abhayaratna
et al. [29].

Cholesterol Biomarkers and Stroke
Several studies have previously demonstrated associations
between lipid and apolipoprotein abnormalities and ischemic
stroke but may [30] or may not have separated subjects by
ischaemic stroke subgroups [31]. As our study did not have a
control group, we cannot comment on changes in lipid biomarker
levels and ischaemic stroke relative to a reference group, however
we found no differences in lipid and lipoprotein levels between
the two ischaemic stroke sub-types suggesting a similar metabolic
profile and that other parameters may be more useful to separate
these two groups.

allowed a small sample size to report significant differences.
Secondly, all patients had a detailed echocardiographic evaluation
by a single experienced provider allowing for novel aspects of
echocardiography and stroke to be evaluated.
In our study, patients were defined as being cardioembolic
if atrial fibrillation was identified and was confirmed by a blinded
classification based on neuro-imaging without reference to cardiac
rhythm. This complete concordance strengthens our assumption
that the left atrium was the source of a cerebral embolus, and was
caused by the presence of atrial fibrillation. This also decreased the
potential that subclinical paroxysmal atrial fibrillation was present
in patients with large artery disease.
Our study did not rigorously examine the mechanism of
development of atrial fibrillation. The higher E:E’ ratio in the CES
group, but similar E’ velocities, was due predominantly to higher
E wave velocities. It is possible the increased E wave velocity
was due to atrial fibrillation rather than diastolic dysfunction,
but the increased left atrial volume, increased left ventricular
mass and higher pulmonary artery pressures suggest possible
diastolic dysfunction. Our study also did not examine patients
with occasional paroxysmal atrial fibrillation, since all of our
patients had persistent atrial fibrillation demonstrated on ECG as
part of their stroke workup, although recent work is noted [32].
Irrespective of the underlying cause of atrial fibrillation, our
study has demonstrated the importance of left atrial volume in
cardioembolic stroke.
Although a larger study size may have identified some
differences in biomarkers between groups, the strength of
association between LAVi and stroke type in our study suggests
this measure is of greater importance. Our study excluded
patients with small vessel disease and stroke of uncertain cause
so replication of our findings in these populations is required.
No patients had alternative cardiac sources of embolism (e.g. left
ventricular thrombus or atrial myxoma), and we acknowledge that
atrial volume may not predict CES if an alternative cardiac source
of embolism is present.

Study Strengths and Limitations

In our study, patients with CES were all demonstrated to have
atrial fibrillation whereas patients with LAS were all demonstrated
to have sinus rhythm including during extended testing. An
independent neurologist unaware of the patient’s rhythm status
independently verified the allocation of patients to CES and LAS
groups. We have not prospectively applied our algorithm to patients
who presented with CES but were in sinus rhythm on arrival. This
would require separate study to fully validate our algorithm.

Our study has several strengths; our patients were extensively
investigated, and the cause of stroke carefully characterized, and
blinded assessment confirmed our allocation into the two groups
(small vessel strokes were excluded from the study). This has

Finally, not every measure was performed in every patient.
The E’, for example, was only measured in 15 patients with LAS
and 12 with CES (due to the presence of atrial fibrillation), which
may explain some non-significant results. Similar problems were
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encountered with estimation of the pulmonary artery systolic
pressure. A larger sample size would help to address this concern.

Conclusions
Left atrial volume indexed for body surface area is the most
important predictor of CES due to atrial fibrillation in our study.
A simple equation based on age, LAVi and E Wave was found to
be highly predictive of CES due to atrial fibrillation, and there was
no additional discriminatory value from lipid and apolipoprotein
measurement. A larger sample size, focusing on measures of
abnormal myocardial relaxation and filling pressures as predictors
of CES, would help clarify the cause for the increase in LAV.
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